JP Patent

JP7417352B2 — Ａｌａｓ１遺伝子の発現を阻害する組成物および方法

Assigned to Icahn School of Medicine at Mount Sinai · Expires 2024-01-18 · 2y expired

What this patent protects

Patent listed against givosiran-sodium.

Drugs covered by this patent

givosiran-sodium (GIVOSIRAN SODIUM)

Patent Metadata

Patent number: JP7417352B2
Jurisdiction: JP
Classification: —
Expires: 2024-01-18
Drug substance claim: No
Drug product claim: No
Assignee: Icahn School of Medicine at Mount Sinai
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.